Curexo Inc. engages in the development and sale of medical devices in South Korea and internationally. It operates through Medical Robot, Implant, and Trading divisions. The company’s products include artificial joint surgery robots, such as CUVIS-joint, ROBODOC, and TSolution One surgical systems; CUVIS-spine, a navigation-based spine surgery robot; Morning Walk S200, a walking rehabilitation robot system; and InMotion Arm, a robotic rehabilitation device used in upper limb rehabilitation. It also sells implants, including artificial joint prostheses; and imports, distributes, and sells food and food additives. The company distributes its products to hospitals, and domestic and overseas agencies. Curexo Inc. was founded in 1992 and is headquartered in Seoul, South Korea.
South Korean Market Performance
7D7 Days: -2.0%
3M3 Months: 20.9%
1Y1 Year: 26.1%
YTDYear to Date: 28.6%
Over the last 7 days, the market has dropped 2.0%, driven by pullbacks in the Materials and Information Technology sectors of 7.0% and 1.3%, respectively. In contrast to the last week, the market is actually up 26% over the past year. As for the next few years, earnings are expected to grow by 22% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.